
SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab
Author(s) -
Antonio Tursi,
Michele Tiano
Publication year - 2021
Publication title -
journal of gastrointestinal and liver diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.641
H-Index - 48
eISSN - 1842-1121
pISSN - 1841-8724
DOI - 10.15403/jgld-3572
Subject(s) - medicine , adalimumab , covid-19 , betacoronavirus , dermatology , medline , virology , pathology , disease , outbreak , infectious disease (medical specialty) , political science , law